Limited field adaptive radiotherapy for glioblastoma: changes in target volume and organ at risk doses.

Radiat Oncol J · 2022 · PMC8984129 · PMID 35368196

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Difference for PTV V 95 was borderline significant for the adaptive boost plan.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.